TTK and prostate carcinoma: ,105,106,107,108,109,110,111,112,113,114 Mps1 expression has been observed in multiple myeloma, osteosarcoma, hepatocellular carcinoma, neuroblastoma, glioma and glioblastoma, prostate cancer, colon cancer, lung cancer, mesothelioma, pancreatic cancer, and has been associated with poor prognosis in multiple cancers.